NEW DELHI: Shares of Sanofi India shed close to 2 percent in early trade Thursday as the drug maker’s October-December results disappointed investors, with the firm’s net profit registering a 27 percent decline in the quarter under review.
The company reported a profit after tax of Rs 90.4 crore in the third quarter of the current financial year as against a net profit of Rs 123 crore the same time a year ago.
Sanofi India’s counter fell to a low of Rs 7,159 as against the previous close of Rs 7,280.40 on the National Stock Exchange.
The drug firm’s sales declined 4.50 percent to Rs 687.90 crore in the quarter ended December 2021 as against Rs 720.30 crore during the previous quarter ended December 2020, reports said. For the full year, the company’s net profit registered a rise of 97.74 percent to Rs 944.40 crore as against Rs 477.60 crore during the previous year ended December 2020.
According to reports, the company’s sales rose 1.88 per cent to Rs 2956.60 crore in the year ended December 2021 as against Rs 2901.90 crore during the previous year ended December 2020.
For the period under review, the company’s total income clocked in at Rs 704.2 crores as against Rs 736.5 crore the same time a year ago.
Sanofi India reported earnings per share of Rs 39.25 in October-December as against Rs 53.41 in the year ago period, reports said.
The company’s board announced a dividend of Rs 181 and a special dividend of Rs 309 per share.